SEC Filing Summary: Healthcare Acquisition Corp. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Healthcare Acquisition Corp. on August 1, 2007. The filing addresses corporate governance events rather than operational financial results. The registrant is a Delaware corporation with principal executive offices in Des Moines, Iowa.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
The material event disclosed is the filing of a Supplement to the Definitive Proxy Statement with the SEC and its mailing to stockholders of record as of June 15, 2007. This supplement pertains to a Special Meeting of stockholders scheduled for August 2, 2007.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factors. The primary focus is the procedural update regarding the upcoming Special Meeting. The Supplement and a related press release are attached as Exhibits 99.1 and 99.2, respectively.
Key Facts for Investor Verification
- Verify the contents of the Proxy Supplement (Exhibit 99.1) to understand the specific proposals for the Special Meeting.
- Confirm the record date of June 15, 2007, to determine eligibility for voting at the August 2, 2007 meeting.
- Note that the company name in the metadata (Altimmune, Inc.) does not match the registrant in the filing text (Healthcare Acquisition Corp.); verify the correct entity for investment purposes.